MALAT1 stereopure antisense oligonucleotide therapy (Wave Life Sciences)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameMALAT1 stereopure antisense oligonucleotide therapy (Wave Life Sciences)

Drug Alias Namerare genetic eye diseases program 1 (WaVe Life Sciences)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionMetastasis Associated Lung Adenocarcinoma Transcript 1 inhibitors

TargetsMetastasis Associated Lung Adenocarcinoma Transcript 1

Therapy Area/IndicationsGenetic Diseases, InbornEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsGenetic Diseases, InbornEye Diseases

ATC CodeN/A